Aprogen Biologics Inc. (KRX:003060)
540.00
-23.00 (-4.09%)
At close: Jan 30, 2026
Aprogen Biologics Company Description
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.
Aprogen Biologics Inc.
| Country | South Korea |
| Founded | 1960 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 391 |
| CEO | Jeong-Chool Kim |
Contact Details
Address: 6, 31, Ogeum-ro 19-gil Seoul South Korea | |
| Phone | 82 2 561 4011 |
| Website | en.aprogen-pharm.com |
Stock Details
| Ticker Symbol | 003060 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003060001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeong-Chool Kim | Chief Executive Officer |
| Jung-Chul Kim | President |